Manpreet Singh, Co-Founder & Principal Consultant at 5TATTVA and CRO of Zeroday Ops Manpreet Singh is the Co-Founder & ...

CrowdStrike’s latest annual Global Threat Report finds AI-driven attacks up 89%, zero-day exploitation surging, and nation-state actors doubling down on cloud and edge device compromise. Since the ...

Feb 23 (Reuters) - Drug developer Generate Biomedicines said on Monday it was targeting a valuation of up to $2.17 billion in its U.S. initial public offering, tapping into a resurgent biotech market ...

Generate:Biomedicines is hoping to raise up to $425 million via a Nasdaq IPO, with the proceeds needed to bankroll its lead antibody through respiratory disease trials. The Flagship Pioneering-founded ...

Generate Biomedicines Inc., a biotechnology firm using artificial intelligence in drug development, is seeking to raise as much as $425 millon in an initial public offering, as listing activity in the ...

Get the latest federal technology news delivered to your inbox. Future U.S. government responses in cyberspace will be “linked to adversary actions” and will involve coordination between the private ...

The Northwest’s only commercial nuclear power plant, the Columbia Generating Station, was manually shut down early Thursday morning due to a mechanical problem. Energy Northwest workers shut the plant ...

Abstract: Adversarial examples threaten the stability of Generative AI (GAI) in consumer electronics (CE), but existing attack strategies either rely solely on gradient information—yielding ...

Generate Biomedicines, Inc. (GENB) has filed to raise public capital in an IPO to advance its pipeline of treatment candidates, according to an SEC filing. The company is developing treatments for ...

Clinical-stage antibody company Generate:Biomedicines is the latest biotech to mull going public as momentum for IPOs continues to build. The Flagship-founded biotech has yet to set out how many ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min Generate:Biomedicines raised ...

Generate Biomedicines Inc. filed for an initial public offering, joining a growing list of biotechnology firms to leap to public markets as investors embrace the sector. The Somerville, ...